Most adults in the US report use social media for health-related engagement, such as research or sharing personal experiences.

A ketogenic diet is associated with improved cognitive and psychiatric factors among adults with schizophrenia and bipolar-1 disorders.

The use of benzodiazepines among older adults in the US decreased and then plateaued after the COVID-19 pandemic.

Former soccer players with a history of traumatic brain injury involving loss of consciousness may face an increased risk for ...

Comorbid sleep disorders among patients with epilepsy are linked to higher SUDEP risk scores and all-cause mortality.

The FDA has accepted Apnimed’s NDA for AD109 (aroxybutynin/atomoxetine), a potential first-in-class oral therapy for adults with obstructive sleep apnea.

The FDA has approved Leqembi Iqlik (lecanemab-irmb) subcutaneous weekly starting dose, enabling fully at-home treatment initiation for early Alzheimer disease.

Individualized cognitive rehabilitation offers significant, sustained improvements for adults with long COVID-related ...

Older adults with a new prescription for a sedative have an increased risk for falls and adverse events in the 30 days after ...

High intake of ultra-processed foods is associated with an increased risk for cognitive impairment, particularly in adults younger than 60 years.

Learn about notable updates that occurred in June 2026 for investigational products in development (not an inclusive list).

Initiating high-efficacy monoclonal antibody therapy before age 18 may reduce long-term disability in pediatric-onset multiple sclerosis.